Jaguar Animal Health Inc (NASDAQ:JAGX) shot up 5.8% during trading on Thursday . The stock traded as high as $2.25 and last traded at $2.00, with a volume of 308,913 shares. The stock had previously closed at $1.89.

Several brokerages have commented on JAGX. Aegis reissued a “buy” rating and set a $10.00 price target on shares of Jaguar Animal Health in a research report on Monday, June 13th. Zacks Investment Research raised shares of Jaguar Animal Health from a “hold” rating to a “buy” rating and set a $2.00 target price on the stock in a report on Wednesday. Finally, Feltl & Co. cut shares of Jaguar Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, March 30th.

The stock’s market cap is $19.47 million. The stock’s 50 day moving average price is $1.77 and its 200 day moving average price is $1.88.

Jaguar Animal Health, Inc is an animal health company focused on developing and commercializing gastrointestinal products for companion and production animals, and horses. The Company is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products. Its pipeline includes prescription drug product candidates for over eight indications across various species and non-prescription products targeting over seven species.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.